| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > PR > PR Performance You Should Expect |
|
Digg It - PR Performance You Should Expect
As a business, non-profit, government agency or association
manager, one way or the other (and sooner or later), you’ll
be paying for some kind of public relations results. And hopefully, results that do something meaningful about the behaviors of those important audiences of yours that MOST affect the organization you manage. Better yet, results that create According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product the kind of external stakeholder
behavior change that leads directly to achieving your
managerial objectives. And even better still when those results reflect how your follow through persuaded those key outside folks to your way of thinking as you helped move them to take actions that allowed your department, group, division or subsidiary to succeed. In ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in my view, the alternative is unacceptable: managers
preoccupied with simple tactics like press releases,
broadcast plugs, special events and brochures, which
deny them the best that public relations has to offer. Instead, what is needed is good public relations planning that really CAN alter individual perception resulting in changed behaviors among key outsid lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. e
audiences. But that only happens when you demand
more than just communications tactics. That’s when
you’ll receive the quality public relations results you
deserve. Results, incidentally, based on a highly proactive premise that can easily go your way: people act on their own perception of the facts before them, which leads to predictable behaviors ab here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe out which something can be done.
When we create, change or reinforce that opinion by
reaching, persuading and moving-to-desired-action the
very people whose behaviors affect the organization the
most, the public relations mission is usually accomplished. When managers adopt such an approach to public relations, the desired end-products should soon emerge. F d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro or instance,
prospects begin to do business with you; membership
applications start to rise; welcome bounces in show room
visits occur; customers starting to make repeat purchases;
capital givers or specifying sources beginning to look your
way; new proposals for strategic alliances and joint ventures
start showing up; politicians and legislators begin loo ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc king
at you as a key member of the business, non-profit or
association communities; and community leaders begin to
seek you out. Still another epiphany occurs when you realize that the public relations people on your staff can be of real use for your new opinion monitoring project. After all, they’re already in the perception and behavior business. But to easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi e
certain, determine if those PR folks really accept why it’s
SO important to know how your most important outside
audiences perceive your operations, products or services.
And this is really important: be sure they believe that
perceptions almost always result in behaviors that can
help or hurt your operation. Is your PR plan now complete? Better sit dow nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically n and review
it carefully with the public relations professionals on your
team, be they agency, staff or parent. Discuss how you will
monitor and gather perceptions by questioning members
of your most important outside audiences. Ask questions
like these: how much do you know about our organization?
Have you had prior contact with us and were you pleased
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ with the exchange? Are you familiar with our services or
products and employees? Have you experienced problems
with our people or procedures? If you decide that, instead of mobilizing your PR staff as key audience data gatherers, you may try professional survey firms to do the job. Just know that that may require more expense than using those PR folks of yo ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi urs in that monitoring
capacity. But whether it’s your people or a survey firm
asking the questions, the objective remains the same: identify
untruths, false assumptions, unfounded rumors, inaccuracies, misconceptions and any other negative perception that might
translate into hurtful behaviors. The most serious problem areas uncovered during your key audie ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a nce perception monitoring call for setting a realistic,
achievable PR goal. For example, will your goal be to
straighten out a dangerous misconception? Correct a gross
inaccuracy? Or, stop a potentially painful rumor before it
does more damage? To show you how to reach that new goal, a matching strategy should be established. However, there are only three s dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod trategic
options available to you when it comes to solving perception
and opinion problems. Change existing perception, create
perception where there may be none, or reinforce it. But the
wrong strategy pick will taste like raspberry jam on your
collard greens . So be certain your new strategy fits well with
your new public relations goal. You certainly do cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin n’t want to
select “change” when the facts dictate a strategy of
reinforcement. One of the keys to success in public relations is the persuasive message, one that helps move a key audience to your way of thinking. It must be carefully written, and aimed directly at your key external audience. Lean on your best writer to accept the assignment because s/he tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen must produce language that is not merely compelling,
persuasive and believable, but clear and factual if it is to
shift perception/opinion towards your point of view and
lead to the behaviors you have in mind. Who will carry that message to the attention of your target audience? Well, with your message written, approved and ready to go, you and your people t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel must
answer that question this way:“Communications tactics.”
And there is no shortage of such tactics available to you.
From speeches, facility tours, emails and brochures to
consumer briefings, media interviews, newsletters,
personal meetings and many others. But be certain that
the tactics you pick are known to reach folks just like
your audience membe ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust rs. It’s an unfortunate, but true aspect of public relations that HOW you communicate your message will bear heavily on its believability, always fragile at best. Which is why you may wish to unveil your corrective message before smaller meetings and presentations rather than using higher-profile news releases. Fact is, a second perception monitoring sessi y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products on will be
needed to measure your progress in moving key audience
perception,. The results will be your first progress report.
Happily, you can use many of the same questions used in
your benchmark session. But now, you will be watching
for signs that the bad news perception is being altered in
your direction. Oh, yes. Because a program occasionally can l . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ose some
of its early velocity, here are two remedies. Either add
more communications tactics, or increase their frequencies,
or both. And finally, publicity placements are satisfying, but when it’s REAL public relations performance you want, you had best shoot for creating the kind of external stakeholder behavior change that leads directly to achieving elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip your
managerial objectives. And do so by persuading those key
outside folks to your way of thinking by helping move
them to take actions that allow your unit to succeed. Please feel free to publish this article and resource box in your ezine, newsletter, offline publication or website. A copy would be appreciated at bobkelly@TNI.net. Robert A. Kelly © 2006 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Venture Capital - Is It The Best Way To Go, Or The Worst? Building Mailing Lists: 7 Ways to Grow Your List From Scratch Let Your Words Speak for You: Increasing Expert Credibility in Your Industry or Profession
|